Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy

AUTOR(ES)

Inoue, Akira

FONTE

Public Library of Science

RESUMO

Gefitinib and erlotinib are two new treatments for advanced lung cancer. Gene mutations in the cancer may help predict which patients will respond to these treatments

Documentos Relacionados

• The molecular basis of lung cancer: molecular abnormalities and therapeutic implications
• Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model.
• Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives
• Antiangiogenic gene therapy of cancer: recent developments
• Laparoscopic nephrectomy for xanthogranulomatous pyelonephritis: are there predictive factors for success?